Gaipa, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 6.680
AS - Asia 3.024
EU - Europa 2.917
SA - Sud America 419
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
Totale 13.109
Nazione #
US - Stati Uniti d'America 6.521
SG - Singapore 1.229
CN - Cina 807
IT - Italia 566
RU - Federazione Russa 430
SE - Svezia 426
DE - Germania 414
HK - Hong Kong 389
BR - Brasile 353
IE - Irlanda 303
VN - Vietnam 225
GB - Regno Unito 183
UA - Ucraina 169
CA - Canada 119
IN - India 93
FI - Finlandia 72
FR - Francia 70
TR - Turchia 60
ID - Indonesia 53
BE - Belgio 51
NL - Olanda 40
PL - Polonia 39
DK - Danimarca 37
BD - Bangladesh 35
ES - Italia 30
KR - Corea 29
AT - Austria 28
MX - Messico 28
AR - Argentina 27
ZA - Sudafrica 25
JP - Giappone 22
EC - Ecuador 11
EU - Europa 11
IQ - Iraq 11
CO - Colombia 10
PK - Pakistan 10
CZ - Repubblica Ceca 9
RO - Romania 8
AU - Australia 7
IL - Israele 7
IR - Iran 7
EG - Egitto 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
LT - Lituania 5
MA - Marocco 5
NO - Norvegia 5
UY - Uruguay 5
AL - Albania 4
BG - Bulgaria 4
LK - Sri Lanka 4
PH - Filippine 4
PY - Paraguay 4
TW - Taiwan 4
AZ - Azerbaigian 3
CH - Svizzera 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
NG - Nigeria 3
NP - Nepal 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
LV - Lettonia 2
MU - Mauritius 2
MY - Malesia 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 13.109
Città #
Ann Arbor 1.404
Singapore 694
Ashburn 577
Woodbridge 454
Chandler 390
Hong Kong 384
Fairfield 378
Wilmington 355
Houston 301
Dublin 295
Frankfurt am Main 254
Jacksonville 180
Milan 173
New York 171
Dearborn 157
Seattle 153
Beijing 132
Cambridge 122
Los Angeles 114
Princeton 99
Santa Clara 99
Shanghai 79
Dallas 73
Ho Chi Minh City 70
Nanjing 67
Hefei 59
Altamura 53
Buffalo 51
Brussels 47
Lawrence 47
Chicago 44
Lissone 44
Jakarta 41
The Dalles 39
Moscow 36
Fremont 35
Warsaw 35
Munich 34
São Paulo 34
Guangzhou 33
San Diego 33
Council Bluffs 32
Lachine 30
Denver 29
Dong Ket 29
Hanoi 28
Toronto 27
Boardman 26
Hangzhou 26
Helsinki 25
London 24
Seoul 24
Nanchang 22
Vienna 21
Montreal 20
San Jose 20
Tokyo 20
Jinan 19
Kocaeli 18
Tianjin 18
Boston 17
Andover 16
Hebei 16
Johannesburg 16
Shenyang 16
Brooklyn 15
Nuremberg 15
Orem 14
Poplar 14
Rio de Janeiro 14
Stockholm 14
Zhengzhou 14
Atlanta 13
Mexico City 13
Ottawa 13
Phoenix 13
Salt Lake City 13
Ankara 12
Pune 12
Edmonton 11
Kunming 11
Monza 11
Ningbo 11
Belo Horizonte 10
Chennai 10
Dhaka 10
Mountain View 10
Amsterdam 9
Casalecchio di Reno 9
Jiaxing 9
Kent 9
Mumbai 9
Redmond 9
Rome 9
San Francisco 9
Turku 9
Columbus 8
Curitiba 8
Portsmouth 8
Turin 8
Totale 8.765
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 423
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 393
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 389
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 388
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 374
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 364
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 359
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 353
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 343
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 337
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 336
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 321
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 317
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 314
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 306
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 296
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 296
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 277
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 273
Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice 261
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 258
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 256
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 245
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 240
Simultaneous over-expression of graft protective hHO-1, hCD73 and hCD39: effects against cell cytotoxicity and cell death induced by the inflammatory cytokine TNF-α in an in vitro model 233
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 232
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 231
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 230
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 229
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 227
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 225
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 224
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 218
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 218
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 212
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 208
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 203
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 203
Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response 193
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies 190
Simultaneous expression of novel combinations of graft protective human genes in porcine endothelial cells 187
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 184
Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling 183
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 181
Noonan Syndrome Peripheral Blood Cells Show Enhanced Spontaneous Colonies Growth In Vitro and Hyperactive JAK and RAS Intracellular Signalling Pathways 171
Linking cell function with perfusion: Insights from the transcatheter delivery of bone marrow-derived CD133 + cells in ischemic refractory cardiomyopathy trial (RECARDIO) 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 165
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 160
aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection 147
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 145
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 142
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 138
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 137
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 126
Monitoring of minimal residual disease in leukemia, advantages and pitfalls 122
Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining 112
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study 43
Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance 42
Totale 13.580
Categoria #
all - tutte 43.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.865


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021956 0 0 0 0 0 139 149 107 135 177 93 156
2021/2022986 99 116 114 75 56 75 41 49 91 85 69 116
2022/20231.460 153 476 107 144 71 209 37 85 100 9 43 26
2023/2024950 29 29 48 50 132 245 184 32 51 26 18 106
2024/20252.064 100 187 89 101 184 94 88 86 273 330 199 333
2025/20263.311 715 276 438 742 818 322 0 0 0 0 0 0
Totale 13.580